Mundipharma today announced positive Phase III topline results from the global ReSPECT clinical trial evaluating REZZAYO ® (rezafungin acetate) for prophylaxis of invasive fungal diseases (IFDs) in ...
To provide an updated joint ASCO/Infectious Diseases Society of America (IDSA) guideline on antimicrobial prophylaxis for adult patients with immunosuppression associated with cancer and its treatment ...
An interview with Dr. Randy Taplitz from UC San Diego Health on the guideline update which addresses antimicrobial prophylaxis for adult patients with immunosuppression associated with cancer and its ...
"We know definitively that we can prevent almost all bleeding – decreasing bleeding frequency by > 90% as well as the severity of bleeding episodes – by continuing prophylaxis into adulthood or ...
Cancer patients at patient advocacy events voice strong support for company's focus on patient quality of life and the highly neglected need for new therapies for cancer therapy-related diarrhea SAN ...